Study on the search for factors, including Kampo medicine treatment, that affect adverse symptoms associated with endocrine therapy and work activity in breast cancer patients.

UMIN ID: UMIN000054353

Registered date:09/05/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: breast cancer
• Date of first enrollment: 2024/05/01
• Target sample size: 160
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: subjective symptoms
• Secondary Outcome: EQ-5D-5L WPAI-GH FACT-B

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Female
• Exclude criteria: (1) Have a serious concomitant disease (liver disease: cirrhosis, renal disease: on dialysis, cardiac disease: chronic heart failure, hematological disease: leukemia, or metabolic disease: poorly controlled diabetes, etc.) (2) Women who are pregnant, may become pregnant (only if they wish to become pregnant during the study period), or are breastfeeding (3) Have concurrent overlapping cancers (4) Any other cases in which the principal investigator or subinvestigator determines that the subject is inappropriate as a research subject.

Related Information

• Primary Sponsor: Tohoku University
• Source(s) of Monetary Support: Other